Company Market News

Centessa Pharmaceuticals plc (NASDAQ: CNTA)
8:00 PM UTC, 06/20/25
Last: $12.43 Change: -0.25 %Change: -1.97% Volume: 1,612,616
News Headlines for CENTESSA PHARMACEUTICALS
06/20/2025 11:16am European Equities Traded in the US as American Depositary Receipts Retreat Friday
06/18/2025 11:15am European Equities Traded in the US as American Depositary Receipts Edge Higher Wednesday
06/16/2025 3:50pm Sector Update: Health Care Stocks Retreat Late Afternoon
06/16/2025 10:32am Centessa Gets US FDA"s Clearance to Start Phase 1 Trial of ORX142 for Neurological, Neurodegenerative Disorders
06/05/2025 11:22am European Equities Traded in the US as American Depositary Receipts Rise Thursday
06/04/2025 11:18am European Equities Traded in the US as American Depositary Receipts Advance Wednesday
05/28/2025 7:12am Needham Initiates Centessa Pharmaceuticals ADR at Buy With $35 Price Target
05/20/2025 5:48pm Centessa Pharmaceuticals Insider Sold Shares Worth $699,111, According to a Recent SEC Filing
05/14/2025 7:32am Centessa Pharmaceuticals Posts Revenue, Q1 Net Loss Narrows
05/14/2025 7:18am -- Earnings Flash (CNTA) Centessa Pharmaceuticals Posts Q1 License and Other Revenue of $15M
05/14/2025 7:16am -- Earnings Flash (CNTA) Centessa Pharmaceuticals Posts Q1 Net Loss $0.20 a Share, vs. FactSet Est of $0.37 Loss
05/08/2025 6:14am Chardan Initiates Centessa Pharmaceuticals at Buy With $30 Price Target
04/22/2025 5:47pm Centessa Pharmaceuticals Insider Sold Shares Worth $681,576, According to a Recent SEC Filing
03/31/2025 7:34am Piper Sandler Initiates Centessa Pharmaceuticals at Overweight With $38 Price Target
01/07/2025 8:01am TD Cowen Initiates Centessa Pharmaceuticals ADR at Buy
12/31/2024 1:22pm Centessa Pharmaceuticals Secures Loan Facility, Repays Debt
11/13/2024 6:43am Morgan Stanley Lifts Price Target on Centessa Pharmaceuticals to $27 From $26, Keeps Overweight Rating
11/12/2024 8:49am Centessa Pharmaceuticals" Q3 Loss Widens
11/12/2024 8:49am Centessa Pharmaceuticals" Q3 Loss Widens
09/20/2024 2:49pm Centessa Pharmaceuticals Shares Rise After Upgrade From Morgan Stanley
09/20/2024 11:07am European Equities Traded in the US as American Depositary Receipts Decrease Friday
09/20/2024 11:07am European Equities Traded in the US as American Depositary Receipts Decrease Friday
09/20/2024 5:39am Morgan Stanley Upgrades Centessa Pharmaceuticals to Overweight From Equalweight, Adjusts PT to $26 From $11
09/19/2024 7:38am Update: B. Riley Initiates Centessa Pharmaceuticals at Buy With $33 Price Target
09/19/2024 5:50am B. Riley Initiates Centessa Pharmaceuticals at Buy



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2020 Wall Street Horizon, Inc.